| Target Price | A$21.19 |
| Price | A$19.56 |
| Potential |
8.34%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target McMillan Shakespeare 2027 .
The average McMillan Shakespeare target price is A$21.19.
This is
8.34%
register free of charge
A$24.15
23.47%
register free of charge
A$20.10
2.76%
register free of charge
|
|
| A rating was issued by 10 analysts: 5 Analysts recommend McMillan Shakespeare to buy, 5 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the McMillan Shakespeare stock has an average upside potential 2027 of
8.34%
register free of charge
|
| Jun '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million A$ | 563.48 | 599.54 |
| 8.15% | 6.40% | |
| EBITDA Margin | 43.65% | 29.43% |
| 1.41% | 32.58% | |
| Net Margin | 16.92% | 17.49% |
| 5.51% | 3.37% |
8 Analysts have issued a sales forecast McMillan Shakespeare 2026 . The average McMillan Shakespeare sales estimate is
This results in the following potential growth metrics:
8 Analysts have issued an McMillan Shakespeare EBITDA forecast 2026. The average McMillan Shakespeare EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
8 McMillan Shakespeare Analysts have issued a net profit forecast 2026. The average McMillan Shakespeare net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Jun '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share A$ | 1.37 | 1.51 |
| 15.13% | 10.22% | |
| P/E | 12.96 | |
| EV/Sales | 3.47 |
8 Analysts have issued a McMillan Shakespeare forecast for earnings per share. The average McMillan Shakespeare EPS is
This results in the following potential growth metrics and future valuations:
McMillan Shakespeare...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BELL POTTER SECURITIES |
Locked
➜
Locked
|
Locked | Jul 01 2026 |
| MACQUARIE RESEARCH |
Locked
➜
Locked
|
Locked | Jun 18 2026 |
| MACQUARIE RESEARCH |
Locked
➜
Locked
|
Locked | Mar 02 2026 |
| BELL POTTER SECURITIES |
Locked
➜
Locked
|
Locked | Feb 26 2026 |
| CANACCORD GENUITY |
Locked
➜
Locked
|
Locked | Feb 23 2026 |
| BELL POTTER SECURITIES |
Locked
➜
Locked
|
Locked | Nov 11 2025 |
| CANACCORD GENUITY |
Locked
➜
Locked
|
Locked | Oct 28 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
BELL POTTER SECURITIES:
Locked
➜
Locked
|
Jul 01 2026 |
|
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
|
Jun 18 2026 |
|
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
|
Mar 02 2026 |
|
Locked
BELL POTTER SECURITIES:
Locked
➜
Locked
|
Feb 26 2026 |
|
Locked
CANACCORD GENUITY:
Locked
➜
Locked
|
Feb 23 2026 |
|
Locked
BELL POTTER SECURITIES:
Locked
➜
Locked
|
Nov 11 2025 |
|
Locked
CANACCORD GENUITY:
Locked
➜
Locked
|
Oct 28 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


